Genscript Biotech Statistics
Total Valuation
HKG:1548 has a market cap or net worth of HKD 24.27 billion. The enterprise value is 20.68 billion.
| Market Cap | 24.27B |
| Enterprise Value | 20.68B |
Important Dates
The last earnings date was Sunday, March 15, 2026.
| Earnings Date | Mar 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:1548 has 2.19 billion shares outstanding. The number of shares has decreased by -0.50% in one year.
| Current Share Class | 2.19B |
| Shares Outstanding | 2.19B |
| Shares Change (YoY) | -0.50% |
| Shares Change (QoQ) | +1.10% |
| Owned by Insiders (%) | 0.21% |
| Owned by Institutions (%) | 15.91% |
| Float | 1.38B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 40.69 |
| PS Ratio | 3.25 |
| PB Ratio | 0.79 |
| P/TBV Ratio | 0.79 |
| P/FCF Ratio | 12.91 |
| P/OCF Ratio | 9.58 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 298.23, with an EV/FCF ratio of 10.99.
| EV / Earnings | -4.99 |
| EV / Sales | 2.77 |
| EV / EBITDA | 298.23 |
| EV / EBIT | n/a |
| EV / FCF | 10.99 |
Financial Position
The company has a current ratio of 1.50, with a Debt / Equity ratio of 0.09.
| Current Ratio | 1.50 |
| Quick Ratio | 1.31 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 1.05 |
| Debt / FCF | 1.43 |
| Interest Coverage | 14.76 |
Financial Efficiency
Return on equity (ROE) is -12.85% and return on invested capital (ROIC) is 7.30%.
| Return on Equity (ROE) | -12.85% |
| Return on Assets (ROA) | 3.15% |
| Return on Invested Capital (ROIC) | 7.30% |
| Return on Capital Employed (ROCE) | 6.18% |
| Weighted Average Cost of Capital (WACC) | 8.77% |
| Revenue Per Employee | 1.21M |
| Profits Per Employee | -672,709 |
| Employee Count | 6,165 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 11.50 |
Taxes
In the past 12 months, HKG:1548 has paid 481.57 million in taxes.
| Income Tax | 481.57M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.57% in the last 52 weeks. The beta is 0.92, so HKG:1548's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | -8.57% |
| 50-Day Moving Average | 12.15 |
| 200-Day Moving Average | 15.01 |
| Relative Strength Index (RSI) | 44.51 |
| Average Volume (20 Days) | 9,001,154 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1548 had revenue of HKD 7.47 billion and -4.15 billion in losses. Loss per share was -1.91.
| Revenue | 7.47B |
| Gross Profit | 4.31B |
| Operating Income | 1.99B |
| Pretax Income | -3.66B |
| Net Income | -4.15B |
| EBITDA | 2.48B |
| EBIT | 1.99B |
| Loss Per Share | -1.91 |
Balance Sheet
The company has 6.32 billion in cash and 2.68 billion in debt, with a net cash position of 3.64 billion or 1.66 per share.
| Cash & Cash Equivalents | 6.32B |
| Total Debt | 2.68B |
| Net Cash | 3.64B |
| Net Cash Per Share | 1.66 |
| Equity (Book Value) | 30.86B |
| Book Value Per Share | 14.14 |
| Working Capital | 2.79B |
Cash Flow
In the last 12 months, operating cash flow was 2.53 billion and capital expenditures -653.03 million, giving a free cash flow of 1.88 billion.
| Operating Cash Flow | 2.53B |
| Capital Expenditures | -653.03M |
| Depreciation & Amortization | 493.84M |
| Net Borrowing | 600.26M |
| Free Cash Flow | 1.88B |
| FCF Per Share | 0.86 |
Margins
Gross margin is 57.65%, with operating and profit margins of 26.60% and -55.53%.
| Gross Margin | 57.65% |
| Operating Margin | 26.60% |
| Pretax Margin | -49.04% |
| Profit Margin | -55.53% |
| EBITDA Margin | 33.18% |
| EBIT Margin | 26.60% |
| FCF Margin | 25.18% |
Dividends & Yields
HKG:1548 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.50% |
| Shareholder Yield | 0.50% |
| Earnings Yield | -17.09% |
| FCF Yield | 7.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |